The immunobiology of aluminium adjuvants: how do they really work?

Trends in Immunology

Volumn 31, Issue 3, 2010, Pages 103-109

  Exley, Christopher ^a   Siesjö, Peter ^b   Eriksson, Håkan ^c  

^a KEELE UNIVERSITY   (United Kingdom)

^b Glioma Immunotherapy Group   (Sweden)

^c MALMÖ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINIUM HYDROXYPHOSPHATE; ALUMINUM; ALUMINUM OXYHYDROXIDE AL 26; ALUMINUM POTASSIUM SULFATE; ALUMINUM SALT; IMJECT; IMMUNOLOGICAL ADJUVANT; IRON; MAGNESIUM; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ARTICLE; DRUG ACTIVITY; DRUG FORMULATION; DRUG MECHANISM; DRUG SOLUBILITY; HUMAN; IMMUNE SYSTEM; IMMUNOBIOLOGY; INJECTION SITE; INNATE IMMUNITY; NONHUMAN; OXIDATION; VACCINATION;

ADAPTIVE IMMUNITY; ADENOSINE TRIPHOSPHATE; ADJUVANTS, IMMUNOLOGIC; ALUMINUM COMPOUNDS; ALUMINUM HYDROXIDE; ANIMALS; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; EXTRACELLULAR FLUID; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; MAGNESIUM COMPOUNDS; MODELS, IMMUNOLOGICAL; MUSCLE, SKELETAL; OXIDATION-REDUCTION; PHAGOCYTES; PHOSPHATES; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES; VACCINES;

EID: 77949330370     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2009.12.009     Document Type: Article

References (72)

1. Li H., Nookala S., and Re F. Aluminium hydroxide adjuvants activate caspase-1 and induce IL-1β and IL-18 release. J. Immunol. 178 (2007) 5271-5276
2. Li H., et al. Cutting edge: Inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181 (2008) 17-21
3. Kool M., et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205 (2008) 869-882
4. Eisenbarth S.C., et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453 (2008) 1122-1126
5. Franchi L., and Núñez G. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1β secretion but dispensable for adjuvant activity. Eur. J. Immunol. 38 (2008) 2085-2089
6. Wang H.-B., and Weller P.F. Pivotal advance: Eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production. J. Leukoc. Biol. 83 (2008) 817-821
7. Hornung V., et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilisation. Nature Immunol. 9 (2008) 847-856
8. Lambrecht B.N., et al. Mechanism of action of clinically approved adjuvants. Curr. Opin. Immunol. 21 (2009) 23-29
9. Marrack P., McKee A.S., and Munks M.W. Towards an understanding of the adjuvant action of aluminium. Nature Rev. Immunol. 9 (2009) 267-293
10. Aimanianda V., et al. Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants. Trends Pharm. Sci. 30 (2009) 287-295
11. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54 (1989) 1-13
12. Hem S.L., and HogenEsch H. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation. Expert Rev. Vaccines 6 (2007) 685-698
13. Martin R.B. The chemistry of aluminium as related to biology and medicine. Clin. Chem. 32 (1986) 1797-1806
14. Jang M., Cho I., and Callahan P. Adsorption of globular proteins to vaccine adjuvants. J. Biochem. Mol. Biol. 30 (1997) 346-351
15. Jiang D., et al. Relationship of adsorption mechanism of antigens by aluminium-containing adjuvants to in vitro elution in interstitial fluid. Vaccine 24 (2006) 1665-1669
16. Méndez I.Z.R., et al. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants. Vaccine 25 (2007) 825-833
17. Exley C., and Birchall J.D. The cellular toxicity of aluminium. J. Theor. Biol. 159 (1992) 83-98
18. Bigay J., et al. Fluoride complexes of aluminum and beryllium act on G-proteins as reversibly bound analogs of the gamma-phosphate of GTP. EMBO J. 6 (1987) 2907-2913
19. MacDonald T.L., and Martin R.B. Aluminium ion in biological systems. Trends Biochem. Sci. 13 (1988) 15-19
20. 26Al. Vaccine 15 (1997) 1314-1318
21. Ramesh M., et al. Effects of the physico-chemical nature of two biomimetic crystals on the innate immune response. Int. Immunopharmacol. 7 (2007) 1617-1629
22. Shi Y., Evans J.E., and Rock K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425 (2003) 516-521
23. Goto N., et al. Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties. Vaccine 15 (1997) 1364-1371
24. Lukiw W.J., Percy M.E., and Kruck T.P. Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture. J. Inorg. Biochem. 99 (2005) 1895-1898
25. Campbell A., et al. Pro-inflammatory effects of aluminium in human glioblastoma cells. Brain Res. 933 (2002) 60-65
26. Tsunoda M., and Sharma R.P. Modulation of tumor necrosis factor alpha expression in mouse brain after exposure to aluminum in drinking water. Arch. Toxicol. 73 (1999) 419-426
27. Ghribi O., et al. Abeta(1-42) and aluminum induce stress in the endoplasmic reticulum in rabbit hippocampus, involving nuclear translocation of gadd 153 and NF-kappa B. Mol. Brain Res. 96 (2001) 30-38
28. Johnson V.J., and Sharma R.P. Aluminum disrupts the pro-inflammatory cytokine/neurotrophin balance in primary brain rotation-mediated aggregate cultures: Possible role in neurodegeneration. Neurotoxicology 24 (2003) 261-268
29. Campbell A., et al. Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J. Neurosci. Res. 75 (2004) 565-572
30. Becaria A., et al. Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain. J. Neuroimmunol. 176 (2006) 16-23
31. Lukiw W.J., and Pogue A.I. Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J. Inorg. Biochem. 101 (2007) 1265-1269
32. Exley C. The prooxidant activity of aluminium. Free Rad. Biol. Med. 36 (2004) 380-387
33. 42. Free Rad. Biol. Med. 40 (2006) 557-569
34. Cruz C.M., et al. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 282 (2007) 2871-2879
35. Pelegrin P., and Surprenant A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1β release through pyrophosphates. EMBO J. 28 (2009) 2114-2127
36. Korchazhkina O., Wright G., and Exley C. No effect of aluminium upon the hydrolysis of ATP in the coronary circulation of the isolated working rat heart. J. Inorg. Biochem. 76 (1999) 121-126
37. Korchazhkina O.V., Wright G., and Exley C. Action of Al-ATP on the isolated working rat heart. J. Inorg. Biochem. 69 (1998) 153-158
38. Haskò G., and Cronstein B.N. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25 (2004) 33-39
39. Sitkovsky M.V. T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response. Trends Immunol. 30 (2009) 102-108
40. Osawa H., and Matsumoto H. Aluminium triggers malate-independent potassium release via ion channels from the root apex in wheat. Planta 215 (2002) 405-412
41. 7 receptors. J. Biol. Chem. 276 (2001) 125-132
42. Jordan M.B., et al. Promotion of B cell immune responses via an alum-induced myeloid cell population. Science 304 (2004) 1808-1810
43. Zatta P., et al. Aluminium(III) induces alterations on the physical state of the erythrocytic membrane: an ESR evaluation. J. Inorg. Biochem. 65 (1997) 109-114
44. Tassi S., et al. Pathogen-induced interleukin-1β processing and secretion is regulated by a biphasic redox response. J. Immunol. 183 (2009) 1456-1462
45. Caicedo M.S., et al. Soluble and particulate Co-Cr-Mo alloy implant metals activate the inflammasome danger signalling pathway in human macrophages: A novel mechanism for implant debris reactivity. J. Orthopaedic Res. 27 (2009) 847-854
46. Rimaniol A.-C., et al. Aluminium hydroxide adjuvant induces macrophage differentiation towards a specialised antigen-presenting cell type. Vaccine 22 (2004) 3127-3135
47. + T cell differentiation by aluminum-containing adjuvants. Vaccine 25 (2007) 4575-4585
48. Gavin A.L., et al. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signalling. Science 314 (2006) 1936-1938
49. Atwood D.A., and Yearwood B.C. The future of aluminium chemistry. J. Organometal. Chem. 600 (2000) 186-197
50. Beardmore J., and Exley C. Towards a model of non-equilibrium binding of metal ions in biological systems. J. Inorg. Biochem. 103 (2009) 205-209
51. Wigren M., et al. Atheroprotective effects of alum are associated with capture of oxidised LDL antigens and activation of regulatory T cells. Circ. Res. 104 (2009) e62-e70
52. Brunner R., et al. Aluminium per se and in the anti-acid drug sucralfate promotes sensitization via the oral route. Allergy 64 (2009) 890-897
53. Levy R., Shohat L., and Solomon B. Specificity of an anti-aluminium monoclonal antibody toward free and protein-bound aluminium. J. Inorg. Biochem. 69 (1998) 159-163
54. Levy R., et al. Immunodetection of aluminium and aluminium-induced conformational changes in calmodulin-implications in Alzheimer's disease. Cell. Biochem. 189 (1998) 41-46
55. Blake D.A., et al. Metal binding properties of a monoclonal antibody directed toward metal-chelate complexes. J. Biol. Chem. 271 (1996) 27677-27685
56. Exley C. A biogeochemical cycle for aluminium?. J. Inorg. Biochem. 97 (2003) 1-7
57. Exley C., et al. Aluminium toxicokinetics. J. Toxicol. Environ. Health 48 (1996) 569-584
58. Exley C., et al. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med. Hyp. 72 (2009) 135-139
59. Hem S.L., Johnston C.T., and HogenEsch H. Imject Alum is not aluminum hydroxide adjuvant or aluminum phosphate adjuvant. Vaccine 25 (2007) 4985-4986
60. Tam M., et al. Possible roles of magnesium on the immune system. Eur. J. Clin. Nutr. 57 (2003) 1193-1197
61. Yang X.D., et al. Multi-NMR and fluorescence spectra study the effects of aluminum (III) on coenzyme NADH in aqueous solutions. Spectrochim. Acta A-Mol. Biomol. Spectroscopy 59 (2003) 2561-2569
62. Rubartelli A., and Lotze M.T. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 28 (2007) 429-436
63. Touyz R.M. Magnesium in clinical medicine. Front. Biosci. 9 (2004) 1278-1293
64. Li J., et al. Intravenous magnesium for acute myocardial infarction. Cochrane Database System. Rev. 2 (2007) CD002755
65. Beasley R., and Aldington S. Magnesium in the treatment of asthma. Curr. Opin. Allergy Clin. Immunol. 7 (2007) 107-110
66. Dube L., and Granry J.C. The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. Can. J. Anaesthesia 50 (2003) 732-746
67. Wolf F.I., Trapani V., and Cittadini A. Magnesium and the control of cell proliferation: looking for a needle in a haystack. Magnesium Res. 21 (2008) 83-91
68. Mazur A., et al. Magnesium and the inflammatory response: Potential physiopathological implications. Arch. Biochem. Biophys. 458 (2007) 48-56
69. King D.E. Inflammation and elevation of C-reactive protein: does magnesium play a key role?. Magnesium Res. 22 (2009) 57-59
70. Nowacki W., et al. High-magnesium concentration and cytokine production in human whole blood model. Magnesium Res. 22 (2009) 93-96
71. Rochelson B., et al. Magnesium sulfate suppresses inflammatory responses by human umbilical vein endothelial cells (HuVECs) through the NF kappa B pathway. J. Reprod. Immunol. 73 (2007) 101-107
72. Exley C. Darwin, natural selection and the biological essentiality of aluminium and silicon. Trends Biochem. Sci. 34 (2009) 589-593